LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 30

Search options

  1. Article ; Online: New Variants of SARS-CoV-2 and Next Generation of COVID-19 Treatments.

    Khiali, Sajad / Entezari-Maleki, Taher

    Journal of clinical pharmacology

    2022  Volume 62, Issue 9, Page(s) 1055–1058

    MeSH term(s) Antiviral Agents/therapeutic use ; COVID-19/drug therapy ; Humans ; SARS-CoV-2
    Chemical Substances Antiviral Agents
    Language English
    Publishing date 2022-05-21
    Publishing country England
    Document type Journal Article
    ZDB-ID 188980-1
    ISSN 1552-4604 ; 0091-2700 ; 0021-9754
    ISSN (online) 1552-4604
    ISSN 0091-2700 ; 0021-9754
    DOI 10.1002/jcph.2067
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article: Tocilizumab in COVID-19 management: addressing time of starting treatment.

    Khiali, Sajad / Entezari-Maleki, Taher

    European journal of hospital pharmacy : science and practice

    2022  Volume 30, Issue 2, Page(s) e9

    MeSH term(s) Humans ; COVID-19 ; COVID-19 Drug Treatment ; Antibodies, Monoclonal, Humanized/therapeutic use ; SARS-CoV-2
    Chemical Substances tocilizumab (I031V2H011) ; Antibodies, Monoclonal, Humanized
    Language English
    Publishing date 2022-01-06
    Publishing country England
    Document type Letter
    ZDB-ID 2650179-X
    ISSN 2047-9964 ; 2047-9956
    ISSN (online) 2047-9964
    ISSN 2047-9956
    DOI 10.1136/ejhpharm-2021-003149
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Therapeutic Application of Corticosteroids in COVID-19: A Focus on Optimum Dose and Duration of Therapy.

    Khiali, Sajad / Entezari-Maleki, Taher

    Journal of clinical pharmacology

    2021  Volume 61, Issue 9, Page(s) 1145–1148

    MeSH term(s) Adrenal Cortex Hormones ; COVID-19 ; Dexamethasone ; Duration of Therapy ; Humans ; SARS-CoV-2
    Chemical Substances Adrenal Cortex Hormones ; Dexamethasone (7S5I7G3JQL)
    Language English
    Publishing date 2021-07-10
    Publishing country England
    Document type Journal Article ; Comment
    ZDB-ID 188980-1
    ISSN 1552-4604 ; 0091-2700 ; 0021-9754
    ISSN (online) 1552-4604
    ISSN 0091-2700 ; 0021-9754
    DOI 10.1002/jcph.1929
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article: SARS-CoV-2 and probable lung cancer risk.

    Khiali, Sajad / Rezagholizadeh, Afra / Entezari-Maleki, Taher

    BioImpacts : BI

    2022  Volume 12, Issue 3, Page(s) 291–292

    Abstract: The pandemic of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has become a global crisis with a growing number of mortalities and morbidities worldwide. Despite performing numerous researches, there are still considerable unrevealed ... ...

    Abstract The pandemic of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has become a global crisis with a growing number of mortalities and morbidities worldwide. Despite performing numerous researches, there are still considerable unrevealed details regarding the long-term complications and post-infection immunity of the coronavirus disease 2019 (COVID-19). Based on pathophysiological features, SARS-CoV-2 may act similarly as an oncovirus in the lung. This letter summarized three possible oncogenic mechanisms of SARS-CoV-2 that may be associated with lung cancer development.
    Language English
    Publishing date 2022-03-26
    Publishing country Iran
    Document type Journal Article
    ZDB-ID 2604624-6
    ISSN 2228-5660 ; 2228-5652
    ISSN (online) 2228-5660
    ISSN 2228-5652
    DOI 10.34172/bi.2022.23266
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Anticoagulation in COVID-19: DDI Perspective.

    Khiali, Sajad / Entezari-Maleki, Taher

    Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis

    2020  Volume 26, Page(s) 1076029620959457

    MeSH term(s) Anticoagulants/adverse effects ; Anticoagulants/therapeutic use ; Betacoronavirus ; Blood Coagulation/drug effects ; COVID-19 ; Coronavirus Infections/complications ; Coronavirus Infections/drug therapy ; Drug Interactions ; Humans ; Pandemics ; Pneumonia, Viral/complications ; Pneumonia, Viral/drug therapy ; SARS-CoV-2
    Chemical Substances Anticoagulants
    Keywords covid19
    Language English
    Publishing date 2020-09-16
    Publishing country United States
    Document type Letter
    ZDB-ID 1237357-6
    ISSN 1938-2723 ; 1076-0296
    ISSN (online) 1938-2723
    ISSN 1076-0296
    DOI 10.1177/1076029620959457
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Correction to: Empagliflozin and colchicine in patients with reduced left ventricular ejection fraction following ST-elevation myocardial infarction: a randomized, double-blinded, three-arm parallel-group, controlled trial.

    Khiali, Sajad / Taban-Sadeghi, Mohammadreza / Sarbakhsh, Parvin / Khezerlouy-Aghdam, Naser / Entezari-Maleki, Taher

    European journal of clinical pharmacology

    2023  Volume 80, Issue 2, Page(s) 301–303

    Language English
    Publishing date 2023-11-30
    Publishing country Germany
    Document type Published Erratum
    ZDB-ID 121960-1
    ISSN 1432-1041 ; 0031-6970
    ISSN (online) 1432-1041
    ISSN 0031-6970
    DOI 10.1007/s00228-023-03600-6
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: SARS-CoV-2 and probable lung cancer risk

    Sajad Khiali / Afra Rezagholizadeh / Taher Entezari-Maleki

    BioImpacts, Vol 12, Iss 3, Pp 291-

    2022  Volume 292

    Abstract: The pandemic of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has become a global crisis with a growing number of mortalities and morbidities worldwide. Despite performing numerous researches, there are still considerable unrevealed ... ...

    Abstract The pandemic of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has become a global crisis with a growing number of mortalities and morbidities worldwide. Despite performing numerous researches, there are still considerable unrevealed details regarding the long-term complications and post-infection immunity of the coronavirus disease 2019 (COVID-19). Based on pathophysiological features, SARS-CoV-2 may act similarly as an oncovirus in the lung. This letter summarized three possible oncogenic mechanisms of SARS-CoV-2 that may be associated with lung cancer development.
    Keywords covid-19 ; sars-cov-2 ; oncovirus ; lung cancer ; lung fibrosis ; Medicine (General) ; R5-920 ; Biology (General) ; QH301-705.5
    Language English
    Publishing date 2022-05-01T00:00:00Z
    Publisher Tabriz University of Medical Sciences
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  8. Article: Effects of citalopram on blood pressure control in depressive patients with hypertension: A randomized clinical trial.

    Namdar, Hossein / Khani, Elnaz / Khiali, Sajad / Safaie, Naser / Ameli, Hedieh / Rahbari Banaeian, Gholamreza / Entezari-Maleki, Taher

    Journal of cardiovascular and thoracic research

    2024  Volume 16, Issue 1, Page(s) 49–54

    Abstract: Introduction: Since there is a bi-directional interaction between hypertension and depression, we aimed to evaluate the effects of citalopram administration in the management of hypertension.: Methods: A randomized clinical trial was conducted on 72 ... ...

    Abstract Introduction: Since there is a bi-directional interaction between hypertension and depression, we aimed to evaluate the effects of citalopram administration in the management of hypertension.
    Methods: A randomized clinical trial was conducted on 72 patients with concomitant depression and hypertension. The intervention group (n=41) received citalopram 20 mg daily plus anti-hypertensive standard treatment, while the control group (n=31) received only the standard treatment. The study's primary endpoint was in-office blood pressure (BP) measurement at baseline and home BP monitoring in the first and second months after entering the study.
    Results: There were no significant differences in baseline systolic BP (163.3±19.6 vs.164.2±20.3 mm Hg;
    Conclusion: This study supported the beneficial effects of citalopram in lowering BP in patients with concomitant depression and hypertension.
    Language English
    Publishing date 2024-03-13
    Publishing country Iran
    Document type Journal Article
    ZDB-ID 2654729-6
    ISSN 2008-6830 ; 2008-5117
    ISSN (online) 2008-6830
    ISSN 2008-5117
    DOI 10.34172/jcvtr.31849
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: Investigational antiviral drugs for the treatment of COVID-19 patients.

    Beheshtirouy, Samineh / Khani, Elnaz / Khiali, Sajad / Entezari-Maleki, Taher

    Archives of virology

    2022  Volume 167, Issue 3, Page(s) 751–805

    Abstract: In the current pandemic of coronavirus disease 2019 (COVID-19), antiviral drugs are at the center of attention because of their critical role against severe acute respiratory disease syndrome coronavirus 2 (SARS-CoV-2). In addition to designing new ... ...

    Abstract In the current pandemic of coronavirus disease 2019 (COVID-19), antiviral drugs are at the center of attention because of their critical role against severe acute respiratory disease syndrome coronavirus 2 (SARS-CoV-2). In addition to designing new antivirals against SARS-COV-2, a drug repurposing strategy is a practical approach for treating COVID-19. A brief insight about antivirals would help clinicians to choose the best medication for the treatment of COVID-19. In this review, we discuss both novel and repurposed investigational antivirals, focusing on in vitro, in vivo, and clinical trial studies.
    MeSH term(s) Antiviral Agents/therapeutic use ; COVID-19/drug therapy ; Drug Repositioning ; Drugs, Investigational/therapeutic use ; Humans ; Pandemics ; SARS-CoV-2
    Chemical Substances Antiviral Agents ; Drugs, Investigational
    Language English
    Publishing date 2022-02-09
    Publishing country Austria
    Document type Journal Article ; Review
    ZDB-ID 7491-3
    ISSN 1432-8798 ; 0304-8608
    ISSN (online) 1432-8798
    ISSN 0304-8608
    DOI 10.1007/s00705-022-05368-z
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: Comprehensive review on molnupiravir in COVID-19: a novel promising antiviral to combat the pandemic.

    Khiali, Sajad / Khani, Elnaz / B Rouy, Samineh / Entezari-Maleki, Taher

    Future microbiology

    2022  Volume 17, Page(s) 377–391

    Abstract: Despite the progress in the management of COVID-19, effective oral antiviral agents are still lacking. In the present review, the potential beneficial effects of molnupiravir in the management of COVID-19 are discussed. A literature search in Google ... ...

    Abstract Despite the progress in the management of COVID-19, effective oral antiviral agents are still lacking. In the present review, the potential beneficial effects of molnupiravir in the management of COVID-19 are discussed. A literature search in Google Scholar, Scopus, PubMed and clinicaltrials.gov for the relevant articles regarding the pharmacokinetics, pharmacodynamics and clinical trials of molnupiravir in the management of COVID-19 is conducted. Most of the preclinical studies and available clinical trials showed a favorable short-term safety profile of molnupiravir; however, given its possible genotoxic effects, further trials are required to confirm the long-term efficacy and safety of molnupiravir in patients with COVID-19.
    MeSH term(s) Antiviral Agents/pharmacology ; Antiviral Agents/therapeutic use ; COVID-19/drug therapy ; Cytidine/analogs & derivatives ; Humans ; Hydroxylamines ; Pandemics ; SARS-CoV-2
    Chemical Substances Antiviral Agents ; Hydroxylamines ; Cytidine (5CSZ8459RP) ; molnupiravir (YA84KI1VEW)
    Language English
    Publishing date 2022-02-24
    Publishing country England
    Document type Journal Article ; Review
    ZDB-ID 2254620-0
    ISSN 1746-0921 ; 1746-0913
    ISSN (online) 1746-0921
    ISSN 1746-0913
    DOI 10.2217/fmb-2021-0252
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top